| Synonyms: | |
| Status: | Approved (2015) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | R03DX09 |
| UNII: | 90Z2UF0E52 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interleukin-5 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypereosinophilic Syndrome | 4 | D017681 | ClinicalTrials |
| Churg-Strauss Syndrome | 3 | D015267 | ClinicalTrials |
| Granulomatosis with Polyangiitis | 3 | D014890 | ClinicalTrials |
| Nasal Polyps | 3 | D009298 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 3 | D029424 | ClinicalTrials |
| Eosinophilia | 2 | D004802 | ClinicalTrials |
| Eosinophilic Esophagitis | 2 | D057765 | ClinicalTrials |
| Chronic Urticaria | 1 | D000080223 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108429 |
| FDA SRS | 90Z2UF0E52 |
CONTENTS